Emma Roth recently wrote about how the company’s patent fight with True

nafizcristia98

The Apple Watch Series 9 and Watch Ultra 2 were both banned in the US late last year as the result of a patent dispute with medical device maker Masimo. The International Trade Commission (ITC) ruled that the blood oxygen sensors in both devices infringed on patents from Masimo. Read Article > Jess Weatherbed JAN 15 JESS WEATHERBED Apple's Watch workaround to avoid an import ban has reportedly been approved.Word of this comes not from US Customs, but Masimo’s own lawyers in a letter published by 9to5Mac. It says the updated watches "do not contain pulse oximetry functionality," which is a step further than last month's report that Apple engineers were working on new algorithms.

It means Apple can continue importing the Apple Watch Series 9 and Apple Watch Ultra 2 despite the patent infringement dispute — just without blood oxygen reading features enabled. Apple readies Apple Watch Series 9 ban workaround by Binance App Users Data disabling blood oxygen functionality [9TO5MAC] Victoria Song JAN 5 VICTORIA SONG Why the ITC denied staying the Apple Watch ban.The ITC’s opinion on the Apple Watch ban has been unsealed. You can read it at the link below, but there are no big surprises. The gist is the ITC didn’t think Apple proved it would suffer irreparable harm if the ban went through.



But the saga isn’t over yet. Shortly after the ban went into effect, a federal appeals court issued a temporary pause, meaning you can still buy the Series 9 and Ultra. Right now, Apple’s waiting to hear back if proposed changes to the Apple Watch will render this patent beef moot. ITC Apple opinion [DOCUMENTCLOUD] Wes Davis DEC 31, 2023 WES DAVIS Masimo kept winning on the way to its Apple Watch fight.My colleague  helps explain Masimo’s confidence in its Apple Watch fight. In a profile of Joe Kiani today, The Wall Street Journal writes about still more examples. One 2016 win gave Masimo a $300 million dollar payout from Philips and a deal that “ended up generating more than $1 billion” for the company.